Pharmacokinetics and pharmacodynamics of single and multiple doses of prasugrel in healthy native Chinese subjects

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine · 2007 · 6.7K citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +1

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

John T. Brandt, Sandra Close, Stephen J. Iturria et al. · Journal of Thrombosis and Haemostasis · 2007 · 730 citations

Medicine, Pharmacokinetics, Pharmacology +14

Confidence Interval Criteria for Assessment of Dose Proportionality

Brian P. Smith · Pharmaceutical Research · 2000 · 352 citations

Pharmacy, Biostatistics, Dose-response Modeling +13

Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry

Nagy A. Farid, Fabio Garofolo, Ernest Y. K. Wong et al. · Rapid Communications in Mass Spectrometry · 2006 · 124 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +17

The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects

David S. Small, Prajakti A. Kothare, Eunice Yuen et al. · European Journal of Clinical Pharmacology · 2009 · 75 citations

Medicine, Pharmacokinetics, Pharmacology +7